Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Perrigo
PRGO
|
+$659M |
| 2 |
Merck
MRK
|
+$636M |
| 3 |
Las Vegas Sands
LVS
|
+$380M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$375M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$296M |
Top Sells
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$419M |
| 4 |
Goldman Sachs
GS
|
+$314M |
| 5 |
TechnipFMC
FTI
|
+$313M |
Sector Composition
| 1 | Healthcare | 20.08% |
| 2 | Consumer Discretionary | 13.88% |
| 3 | Communication Services | 10.65% |
| 4 | Technology | 10.56% |
| 5 | Energy | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STAY
501
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.66M | 0.01% |
248,551
+55,164
| +29% | +$1.26M |
|
|
RVNC
502
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.51M | 0.01% |
+174,972
| New | +$5.51M |
|
|
AERI
503
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.46M | 0.01% |
257,712
+848
| +0.3% | +$18K |
|
504
Verastem
VSTM
$604M
| $5.43M | 0.01% |
41,970
+140
| +0.3% | +$18.1K |
|
505
InspireMD
NSPR
$100M
| – | – |
0
| – | -$4.32M |
|
506
WSFS Financial
WSFS
$3.15B
| $5.27M | 0.01% |
221,388
-448,419
| -67% | -$10.7M |
|
|
TRNX
507
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $5.07M | ﹤0.01% |
238,712
+769
| +0.3% | +$16.3K |
|
508
IQVIA
IQV
$31.8B
| $5.05M | ﹤0.01% |
99,360
+215
| +0.2% | +$10.9K |
|
509
Kirby Corp
KEX
$4.87B
| $4.92M | ﹤0.01% |
48,609
-213,272
| -81% | -$21.6M |
|
|
SUNE
510
DELISTED
SUNEDISON, INC COM
SUNE
| $4.71M | ﹤0.01% |
+250,164
| New | +$4.71M |
|
511
SPDR S&P 500 ETF Trust
SPY
$668B
| $4.56M | ﹤0.01% |
24,365
-38,143
| -61% | -$7.13M |
|
512
Webster Financial
WBS
$10.2B
| $4.54M | ﹤0.01% |
146,027
+30,186
| +26% | +$938K |
|
|
FL
513
DELISTED
Foot Locker
FL
| $4.37M | ﹤0.01% |
92,964
+47,987
| +107% | +$2.25M |
|
514
Insulet
PODD
$24B
| $4.28M | ﹤0.01% |
90,174
-458,506
| -84% | -$21.7M |
|
515
Omeros
OMER
$293M
| $4.23M | ﹤0.01% |
+350,000
| New | +$4.23M |
|
516
Inovio Pharmaceuticals
INO
$147M
| $4.16M | ﹤0.01% |
+26,042
| New | +$4.16M |
|
|
AENZ
517
DELISTED
Aenza S.A.A. American Depositary Shares (each representing fifteen (15) Common Shares)
AENZ
| $4.13M | ﹤0.01% |
79,697
+2,873
| +4% | +$149K |
|
|
TEN
518
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $4.09M | ﹤0.01% |
70,509
-11,559
| -14% | -$671K |
|
519
Moog
MOG.A
$6.27B
| $3.99M | ﹤0.01% |
60,907
-260,856
| -81% | -$17.1M |
|
520
EQT Corp
EQT
$31.9B
| $3.94M | ﹤0.01% |
74,692
+63,663
| +577% | +$3.36M |
|
521
Johnson & Johnson
JNJ
$426B
| $3.84M | ﹤0.01% |
39,068
+6,003
| +18% | +$590K |
|
522
Brunswick
BC
$4.27B
| $3.84M | ﹤0.01% |
+84,679
| New | +$3.84M |
|
523
Norfolk Southern
NSC
$61.5B
| $3.82M | ﹤0.01% |
39,346
+2,534
| +7% | +$246K |
|
524
BioCryst Pharmaceuticals
BCRX
$1.69B
| $3.79M | ﹤0.01% |
358,557
+1,205
| +0.3% | +$12.8K |
|
525
Archer Daniels Midland
ADM
$29.4B
| $3.76M | ﹤0.01% |
86,588
+10,518
| +14% | +$456K |
|